USPTO serial 88484180
XCOPRI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 11, 2020
- Examiner
- AGREDA, SAMANTHA LEIGH
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with XCOPRI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SK BIOPHARMACEUTICALS CO., LTD.
Seongnam-si, KR
SK BIOPHARMACEUTICALS CO., LTD.
Seongnam-si, KR
SK BIOPHARMACEUTICALS CO., LTD.
Seongnam-si, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Hun Joon Kim
Hun Joon Kim LEX IP Meister, PLLC.5160 Parkstone Drive, Suite 140Chantilly, VA 20151United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes [ and veterinary preparations ] for treatment of central nervous system diseases; [ cancer and metabolic diseases; ] biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases; [ cancer and metabolic diseases; ] chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases; [ cancer and metabolic diseases; ] medical preparation of trace elements for human [ and animal ] use, namely, for the treatment of central nervous system diseases; [ cancer and metabolic diseases; ] biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases; [ cancer and metabolic diseases; ] chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases; [ cancer and metabolic diseases; ] chemical preparations for medical [ or veterinary ] purposes, namely, for the treatment of central nervous system diseases; [ cancer and metabolic diseases; pharmaceutical preparations for immunity adjustment; ] therapeutic drugs and agents for the treatment of central nervous system diseases; [ cancer and metabolic diseases; ] chemico-pharmaceutical preparations for the treatment of central nervous system diseases [ , cancer and metabolic diseases ] | ACTIVE | May 11, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SK BIOPHARMACEUTICALS CO., LTD.
- Other trademarks owned by SK BIOPHARMACEUTICALS CO., LTD.
- Other trademarks owned by SK BIOPHARMACEUTICALS CO., LTD.
- Other trademarks in Class 005
- Similar marks named XCOPRI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 12, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 12, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 12, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 31, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Aug 11, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 27, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 27, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 27, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 27, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 11, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 7, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 6, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 28, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 28, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 11, 2020 | IUAF | USE AMENDMENT FILED | — |
| May 11, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 7, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 11, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 11, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 22, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 2, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 23, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 23, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 6, 2019 | ALIE | ASSIGNED TO LIE | — |
| Nov 27, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 7, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 16, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 16, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 16, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 12, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 3, 2019 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 2, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 25, 2019 | NWAP | NEW APPLICATION ENTERED | — |